ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Nine New Grants Awarded In The NCI “Director’s Challenge”.

October 13, 2000

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

May 24, 1985

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007